| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/23/2023 | Aprea Therapeutics, Inc. | APRE | Grant | Stock Options (Right to Buy) | 12.5k | $3.65 | $45.6k | | 08/23/2023 |
| 05/05/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 8.1k | $0.00 | $0 | | 05/05/2023 |
| 05/05/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Option to Purchase Common Stock | 11.4k | $31.00 | $352.5k | | 05/05/2023 |
| 05/05/2022 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Restricted Stock Units | 6.2k | $0.00 | $0 | | 05/05/2022 |
| 08/25/2021 | HALOZYME THERAPEUTICS, INC. | HALO | Sale | Common Stock | 35k | $41.01 | $1.4M | | 08/25/2021 |
| 05/05/2021 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Restricted Stock Units | 5.2k | $0.00 | $0 | | 05/05/2021 |
| 04/30/2020 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 8.8k | $0.00 | $0 | | 04/30/2020 |
| 01/25/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $3.23 | $64.6k | | 01/25/2020 |
| 05/02/2019 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 12.2k | $0.00 | $0 | | 05/02/2019 |
| 01/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $2.74 | $54.8k | | 01/25/2019 |
| 05/02/2018 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 10.4k | $0.00 | $0 | | 05/02/2018 |